Nuclear sites in Iran: No off-site radiation increase reported 

IAEA has reported “no increase in off-site radiation levels” after the latest strikes on 22 June 2025 on the three Iranian nuclear sites at Fordow, Esfahan and Natanz.  

Based on available information, the International Atomic Energy Agency (IAEA) has confirmed “no off-site radiation increase” from three Iranian nuclear sites of Fordow, Natanz and Esfahan following recent aerial strikes.  

The IAEA assessed that the latest strike in the early morning on 22 June 2025 has led to extensive additional damage at Esfahan site, which had already struck several times since the conflict started on 13 June 2025. Several buildings at the Esfahan complex were damaged, some of which may have contained nuclear material. Also, entrances to tunnels used for the storage of enriched material appear to have been hit. 

The Fordow site is directly impacted. It has visible craters indicative of use of ground-penetrating munitions. Fordow is Iran’s main location for enriching uranium at 60%. The degree of damage inside the uranium enrichment halls could not be immediately assessed because the facility is built deep inside a mountain. Given the type of munition used, and the extreme vibration-sensitive nature of centrifuges, very significant damage is expected to have occurred.    

The Fuel Enrichment Plant at Natanz, which was damaged extensively earlier, was again hit with ground-penetrating munitions. 

The IAEA has called for ending the hostilities so that it could resume verification activities, including of stockpile of more than 400 kg of highly enriched uranium at the sites, which it last verified few days before the conflict began. 

*** 

Sources:  

  1. IAEA.  Update on Developments in Iran (5). Posted 22 June 2025. Available at https://www.iaea.org/newscenter/pressreleases/update-on-developments-in-iran-5 
  1. IAEA Director General’s Introductory Statement to the Board of Governors. 23 June 2025. Available at https://www.iaea.org/newscenter/statements/iaea-director-generals-introductory-statement-to-the-board-of-governors-23-june-2025 

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Resveratrol Can Protect Body Muscle in Mars’ Partial Gravity

The effects of partial gravity (example on Mars) on...

Deep Space Optical Communications (DSOC): NASA tests Laser  

Radio frequency based deep space communication faces constraints due...

DNA for Storage of Vast Computer Data

A breakthrough study takes significant step towards developing a...

Second malaria vaccine R21/Matrix-M recommended by WHO

A new vaccine, R21/Matrix-M has been recommended by the...

Selegiline’s Wide Array of Potential Therapeutic Effects

Selegiline is an irreversible monoamine oxidase (MAO) B inhibitor1....
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.